Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Shares withheld for taxes Director gave up 911 shares (to pay taxes)
  6. 4 Shares withheld for taxes Director gave up 867 shares (to pay taxes)
  7. 4 Planned sale Director sold 2,638 shares at $31.85 ($84,020)
  8. 4 Planned sale Director sold 2,800 shares at $31.50 ($88,200)
  9. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 1,555 shares (to pay taxes)
  10. 4 Planned sale SVP, Chief Commercial Officer sold 27,134 shares at $28.93 ($784,862)
  11. 4 Planned sale Director sold 41,250 shares at $31.24 ($1,288,786)
  12. 4 Derivatives Options or other derivatives
  13. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 2,704 shares (to pay taxes)
  14. 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 2,462 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 3,088 shares (to pay taxes)
  16. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 5,345 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 3,224 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 2,049 shares (to pay taxes)
  19. 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 67,531 shares (to pay taxes)
  20. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 9,839 shares (to pay taxes)

Page 11 of 67 · 1,323 filings